HIGHLIGHTS
- who: Wei Liu from the Department of Respiratory Medicine, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Guangzhou Road, Nanjing, Jiangsu Province, China have published the research: A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The final version of MINORS contained 12 items, the first eight being specifically for non-RCTs: A clearly stated aim; Inclusion of consecutive patients; Prospective collection of data; Endpoint appropriate to the study aim; Unbiased assessment of endpoints; Follow-up period appropriate to the major . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.